The biology of NAD+ decline, the role of NMN as a precursor, and the clinical rationale for topical and transdermal delivery formats targeting cellular energy restoration in aging skin.
Nicotinamide Adenine Dinucleotide (NAD+) is the central coenzyme in cellular energy metabolism — a required cofactor for over 500 enzymatic reactions, including the electron transport chain reactions that generate ATP in mitochondria. In human skin fibroblasts and keratinocytes, NAD+ levels decline by approximately 50% between age 40 and age 70 — a trajectory closely correlated with reduced mitochondrial function, increased oxidative damage, and impaired DNA repair capacity.
Beyond energy metabolism, NAD+ is the obligate substrate for the Sirtuin family of deacetylase enzymes (SIRT1–7) — proteins that regulate epigenetic gene expression, inflammation, autophagy, and mitochondrial biogenesis. Without sufficient NAD+, sirtuin enzymatic activity is severely limited, and the "longevity gene" pathways they govern become functionally silent.
NMN (Nicotinamide Mononucleotide) is the direct biosynthetic precursor to NAD+ — converted in a single enzymatic step by NMNAT (nicotinamide mononucleotide adenylyltransferase). Unlike NAD+ itself — which cannot efficiently cross cell membranes — NMN is transported directly into cells via the Slc12a8 transporter expressed on fibroblasts and other skin cells, making it the kinetically preferred substrate for intracellular NAD+ repletion.
NMN has a molecular weight of 334.2 Da — technically within the passive diffusion threshold for intact skin. However, its hydrophilicity (high water solubility, poor lipid solubility) limits transdermal flux through the lipid-rich stratum corneum. Traditional aqueous serums deliver insufficient NMN to the viable epidermis. The NAD+ Microneedle Patch solves this with 3,600 dissolving microneedles per patch, each 600μm in height — long enough to penetrate the stratum corneum entirely and deposit the NMN payload directly in the viable epidermis, bypassing the lipid barrier entirely.
Spermidine — a naturally occurring polyamine — activates autophagy via mTOR inhibition, clearing cellular debris and aged organelles that impair mitochondrial function. When delivered alongside NMN in the same matrix, spermidine clears the cellular environment through which NAD+ replenishment operates, creating a synergistic effect: NAD+ repletion drives metabolic activity, spermidine removes the accumulated cellular damage that would otherwise resist it.
Explore the NAD+ Microneedle Patch →